Tissue plasminogen activator extravasated through the cerebral vessels: Evaluation using a rat thromboembolic stroke model

Thrombosis and Haemostasis

Volumn 94, Issue 4, 2005, Pages 791-796

  Harada, Tadashi ^a   Kano, Tsuneo ^a   Katayama, Yoichi ^a   Matsuzaki, Toshinori ^a   Tejima, Emiri ^a   Koshinaga, Morimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Extravasation; Fibrinolysis; Rat; Thromboembolic stroke; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HOMOGENATE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EXTRAVASATION; DRUG TISSUE LEVEL; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; STROKE; THROMBOEMBOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FIBRINOLYTIC AGENTS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSENSORY CORTEX; TISSUE PLASMINOGEN ACTIVATOR;

EID: 27144520556     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-03-0164     Document Type: Article

References (30)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
2. Chen Z-L, Stickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91: 917-25.
3. Tsirka SE, Rogove AD, Bugge TH et al. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997; 17: 543-52.
4. Wang YF, Tsirka SE, Strickland S et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nature Med 1998; 4: 228-31.
5. Kano T, Katayama Y, Tejima E et al. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res 2000; 854: 245-8.
6. Tejima E, Katayama Y, Suzuki Y et al. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Stroke 2001; 32: 1336-40.
7. Korninger C, Collen D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 1981; 46: 561-5.
8. Koshinaga M, Katayama Y, Fukushima M et al. Rapid and widespread microglial activation induced by traumatic brain injury in rat brain slices. J Neurotrauma 2000; 17: 185-92.
9. Westergaard E, Go G, Klatzo I et al. Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in mongolian gerbils. Acta Neuropath 1976; 35: 307-25.
10. Ranby M, Nguyen G, Scarabin PY et al. Immunoreactivity of tissue plasminogen activator and its inhibitor complexes. Thromb Haemost 1989; 61: 409-14.
11. Zea Longa E, Weinstein PR, Carlson S et al. Reversible middle cerebral artery occlusion without craniectomy. Stroke 1989; 20: 84-91.
12. Lo EH, Bosque-Hamilton P, Meng W. Inhibition of PARP: reduction of ischemic injury and attenuation of NMDA-induced neurotransmitter dysregulation. Stroke 1998; 29: 830-6.
13. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1989; 1: 974-82.
14. Tsirka SE, Gualandris A, Amaral DG et al. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995; 377: 340-4.
15. Boudreau N, Sympson CJ, Werb Z et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-3.
16. Coucouvanis E, Martin GR. Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell 1995; 83: 279-87.
17. Flavin MP, Zhao G, Ho LT. Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 2000; 29: 347-54.
18. Rogove AD, Siao C, Keyt B et al. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci 1999; 112: 4007-16.
19. Nicole O, Docagne F, Margaill I et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Med 2001; 7: 59-64.
20. Broadwell RD, Balin BJ, Salcman M. Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc Natl Acad Sci USA 1988; 85: 632-6.
21. Nag S, Robertson DM, Dinsdale HB. Quantitative estimate of pinocytosis in experimental acute hypertension. Acta Neuropath 1979; 46: 107-16.
22. Ito U, Ohno K, Yamaguchi T et al. Effect of hypertension on blood-brain barrier change after restoration of blood flow in post-ischemic gerbil brains. Stroke 1980; 11: 606-11.
23. del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in stroke: possibilities and hazards. Stroke 1986; 7: 595-607.
24. Chan PH, Longar S, Fishman RA. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 1987; 21: 540-7.
25. Lyden PD, Zivin JA. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Metab Rev 1993; 5: 1-16.
26. Wang X, Lee S-R, Arai K et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nature Med 2003; 9: 1313-7.
27. Yepes M, Sandkvist M, Moore EG et al. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL-receptor-related protein. J Clin Invest 2003; 112: 1533-40.
28. Asahi M, Asahi K, Jung JC et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 452-7.
29. Rosenberg GA, Navratil M, Barone F et al. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996; 16: 360-6.
30. Heo JH, Lucero J, Abumiya T et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999; 19: 624-33.